Mu minsi ishize, Bayer yatangaje ko Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa (NMPA) cyemeje umuti mushya witwa sevabertinib wo kuvura abarwayi bakuru bafite kanseri y’ibihaha idakira cyangwa idafite utunyangingo duto (NSCLC) bafite HER2 (ERBB2) ituma habaho impinduka mu miterere y’umubiri kandi bakaba barahuye n’indwara nyuma y’uko nibura rimwe mu mavuriro y’umubiri.
Ibi bivuze ko uko waba ukomoka kose, ubu ushobora kubona ubu buvuzi bugezweho ku isi binyuze mu ishami mpuzamahanga ry’ibitaro bya Beijing Region South Oncology Hospital.
Sevabertinib: Kwibanda ku mpinduka za HER2 neza
Sevabertinib ni umuti mushya, ukoreshwa mu kanwa, ushobora kuvurwa, ugashobora kuvurwa. Ugabanya cyane HER2 (harimo no guhindurwa kwa HER2 exon 20) ndetse na EGFR. Ugereranyije na TKI zisanzwe zidahinduka, TKI ishobora kugabanya by'agateganyo kandi neza uwo muti, bigatuma ubuvuzi bugenzurwa neza kandi bugabanye ingaruka mbi z'igihe kirekire.
Gushishikariza amakuru y'ubuvuzi: Ibisubizo by'ingenzi, inyungu zirambye
Kwemezwa kwa sevabertinib bishingiye ku bisubizo byiza byavuye mu igerageza mpuzamahanga ryakozwe mu byiciro byinshi bya SOHO-01 mu cyiciro cya mbere/icya kabiri:
- Ku barwayi batari barahawe ubuvuzi bwa ADC bushingiye kuri HER2
Igipimo cy’ibisubizo bigamije ibisubizo (ORR) cyageze kuri 64%, harimo ibisubizo byuzuye bya 2.5% na 62% by’ibisubizo by’igice. Igihe cy’impuzandengo cy’ibisubizo cyari amezi 9.2.
- Ku barwayi bari barahawe ubuvuzi bwa ADC bushingiye kuri HER2
ORR yari ikiri 38%, harimo ibisubizo byuzuye 5.5% na 33% by'ibisubizo by'igice. Igihe cyo hagati cy'ibisubizo cyari amezi 7.
Imiterere y'umutekano iracungwa neza kandi ijyanye na raporo zabanje, bitanga ishingiro ryizewe ryo kuvurwa igihe kirekire.
Kuki wahitamo Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo?
Nk'ikigo mpuzamahanga cyita ku buvuzi cyibanda ku kwita ku ndwara ya kanseri, dutanga abarwayi ku isi yose:
- Itsinda ry'abaganga bavuga indimi nyinshi: Serivisi mu Gishinwa, Icyongereza, Ikirusiya, Icyarabu, n'ibindi, bigamije gutumanaho neza hose.
- Serivisi z’abarwayi mpuzamahanga zitangwa rimwe: Guhuza ibikorwa bitandukanye kuva ku nama zo kure no gufasha mu bijyanye na viza y’ubuvuzi kugeza ku kwimurirwa ku kibuga cy’indege, gahunda yo kujya mu bitaro, no gukurikirana nyuma yo kuvurwa.
- Gahunda z’ubuvuzi zihariye: Uburyo bwo kuvura bwihariye hamwe na gahunda z’ubuvuzi burambuye bushingiye ku miterere y’umubiri w’umurwayi n’uko amerewe muri rusange.
Twandikire uyu munsi kugira ngo utangire urugendo rwawe rw'ibyiringiro
Ishami Mpuzamahanga ry'Ibitaro bya Oncology byo mu Karere k'Amajyepfo rya Beijing
Telefoni y'umuganga ku barwayi ku isi: 400-880-3716
WeChat: 17801183037
Imeri:
- 100085_010@163.com
- myimmnet@163.com
—
Ubuzima bwawe bukwiye kuvurwa neza kurusha ubundi bwose
Waba ushaka inzira y'icyizere cyangwa wamaze gutera imbere nyuma yo gukoresha imiti myinshi mbere, sevabertinib ishobora gutanga impinduka idasanzwe. Ishami Mpuzamahanga ry'Ibitaro Mpuzamahanga bya Oncology bya Beijing mu Karere k'Amajyepfo ryiteguye kugufungurira inzira y'ibidukikije—hamagara 400-880-3716 ubu, cyangwa uduhamagare kuri WeChat cyangwa imeri. Reka tugufashe kuvugana n'impuguke zikomeye, gusuzuma niba wujuje ibisabwa, no gutegura urugendo rwawe rwo kuvurwa mu Bushinwa.
Ntutegereze. Buri guhamagara bishobora kuba intangiriro nshya.
Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing — Guhuza Abarwayi bo ku Isi n’Ubuvuzi Bwiza bw’Ubushinwa.
Igihe cyo kohereza ubutumwa: 16 Mata 2026